Migraine Drugs Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 weeks by ordering today
Migraine Drugs Market Trends and Forecast
The future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy. The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028. The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Emerging Trends in the Migraine Drugs Market
Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people, and rising R&D investment for the development of innovative drugs for the treatment of migraine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. To learn the scope, benefits, companies researched and other details of the global migraine drugs market report, please download the report brochure.
Migraine Drugs Market by Segments
The study includes trends and forecast for the global migraine drugs market by product type, route of administration, distribution channel, and region, as follows:
Migraine Drugs Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, migraine drugs companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the migraine drugs companies profiled in this report include.
Q1. What is the migraine drugs market size?
Answer: The global migraine drugs market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for migraine drugs market?
Answer: The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the migraine drugs market?
Answer: The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Q4. What are the major segments for migraine drugs market?
Answer: the future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy.
Q5. What are the emerging trends in migraine drugs market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people and rising R&D investment for the development of innovative drugs for the treatment of migraine.
Q6. Who is the key migraine drugs companies?
Answer: Some of the key migraine drugs companies are as follows:
Answer:Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
Q8. In migraine drugs market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the migraine drugs market by product type (acute migraine treatment and preventive migraine treatment), route of administration (oral, injectables, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and what has been the impact on the industry?
For any questions related to migraine drugs market or related to migraine drugs companies, migraine drugs market size, migraine drugs market share, migraine drugs analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
Migraine Drugs Market Trends and Forecast
The future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy. The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028. The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Emerging Trends in the Migraine Drugs Market
Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people, and rising R&D investment for the development of innovative drugs for the treatment of migraine.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. To learn the scope, benefits, companies researched and other details of the global migraine drugs market report, please download the report brochure.
Migraine Drugs Market by Segments
The study includes trends and forecast for the global migraine drugs market by product type, route of administration, distribution channel, and region, as follows:
Migraine Drugs Market by Product Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Acute Migraine Treatment
- Preventive Migraine Treatment
- Oral
- Injectables
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, migraine drugs companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the migraine drugs companies profiled in this report include.
- Allergan
- Abbott Laboratories
- AstraZeneca
- Endo International
- Eisai Co.
- Impax Laboratories
- GlaxoSmithKline
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co.
- Sanofi SA
- Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
- Online pharmacy is expected to remain the fastest growing segment because it provides migraine drugs through e-commerce platforms which is convenient, gives privacy of buying, hassel-free, and saves time by allowing people to refrain from waiting in queues. It is specifically helpful for individuals who live far from a regular pharmacy, the elderly, the crippled, and those who work extensively, this technique of receiving medication is both very simple and quick. In addition, the cost of delivery is far less than the expense of traveling to a regular pharmacy hence, provides additional benefit.
- APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
- Market Size Estimates: Migraine Drugs market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Migraine Drugs market size by various segments, such as product type, route of administration, and distribution channel.
- Regional Analysis: Migraine Drugs market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different product types, routes of administration, distribution channels, and regions for the migraine drugs market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the migraine drugs market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q1. What is the migraine drugs market size?
Answer: The global migraine drugs market is expected to reach an estimated $xx billion by 2028.
Q2. What is the growth forecast for migraine drugs market?
Answer: The global migraine drugs market is expected to grow with a CAGR of 12% to 15% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the migraine drugs market?
Answer: The major drivers for this market are growing cases of migraine due to stress, hormonal changes, and lifestyle diseases, increased uptake of novel drug classes, launch of calcitonin gene-related peptide (CGRP)-based therapies, and growing awareness programs regarding the prevention and treatment of migraine.
Q4. What are the major segments for migraine drugs market?
Answer: the future of the migraine drugs market looks promising with opportunities in various distribution channels, like hospital pharmacy, retail pharmacies, and online pharmacy.
Q5. What are the emerging trends in migraine drugs market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include rapid change in lifestyle of people and rising R&D investment for the development of innovative drugs for the treatment of migraine.
Q6. Who is the key migraine drugs companies?
Answer: Some of the key migraine drugs companies are as follows:
- Allergan Plc.
- Abbott Laboratories
- AstraZeneca
- Endo International Plc.
- Eisai Co. Ltd.
- Impax Laboratories
- GlaxoSmithKline Plc.
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co.
- Sanofi SA
Answer:Lucintel forecasts that acute migraine treatment will remain the largest segment over the forecast period due to ease of self-administration in case of patients with symptoms of nausea and vomiting along with migraine and growing utilization in combination with preventive treatments.
Q8. In migraine drugs market, which region is expected to be the largest in next 5 years?
Answer: APAC will remain the fastest growing region due to rising prevalence of migraine in people due to increasing stress, work pressure, changing lifestyle, and consumption of alcohol, growing public awareness about the disease, rising healthcare spending, and accessibility to healthcare facilities.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the migraine drugs market by product type (acute migraine treatment and preventive migraine treatment), route of administration (oral, injectables, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and what has been the impact on the industry?
For any questions related to migraine drugs market or related to migraine drugs companies, migraine drugs market size, migraine drugs market share, migraine drugs analysis, write Lucintel analyst at email: [email protected] we will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL MIGRAINE DRUGS MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Migraine Drugs Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Migraine Drugs Market by Product Type
3.3.1: Acute Migraine Treatment
3.3.2: Preventive Migraine Treatment
3.4: Global Migraine Drugs Market by Route of Administration
3.4.1: Oral
3.4.2: Injectables
3.4.3: Others
3.5: Global Migraine Drugs Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Migraine Drugs Market by Region
4.2: North American Migraine Drugs Market
4.2.1: North American Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.2.2: North American Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Migraine Drugs Market
4.3.1: European Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.3.2: European Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Migraine Drugs Market
4.4.1: APAC Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.4.2: APAC Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Migraine Drugs Market
4.5.1: ROW Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.5.2: ROW Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
5. COMPETITOR ANALYSIS
5.1: Product Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Migraine Drugs Market by Product Type
6.1.2: Growth Opportunities for the Global Migraine Drugs Market by Route of Administration
6.1.3: Growth Opportunities for the Global Migraine Drugs Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Migraine Drugs Market by Region
6.2: Emerging Trends in the Global Migraine Drugs Market
6.3: Strategic Analysis
6.3.1: New Product Type Development
6.3.2: Capacity Expansion of the Global Migraine Drugs Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Migraine Drugs Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Allergan
7.2: Abbott Laboratories
7.3: AstraZeneca
7.4: Endo International
7.5: Eisai
7.6: Impax Laboratories
7.7: GlaxoSmithKline
7.8: Johnson & Johnson
7.9: Pfizer
7.9: Merck & Co.
7.10: Sanofi SA
2. GLOBAL MIGRAINE DRUGS MARKET: MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2017 TO 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Migraine Drugs Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Migraine Drugs Market by Product Type
3.3.1: Acute Migraine Treatment
3.3.2: Preventive Migraine Treatment
3.4: Global Migraine Drugs Market by Route of Administration
3.4.1: Oral
3.4.2: Injectables
3.4.3: Others
3.5: Global Migraine Drugs Market by Distribution Channel
3.5.1: Hospital Pharmacies
3.5.2: Retail Pharmacies
3.5.3: Online Pharmacies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2017 TO 2028
4.1: Global Migraine Drugs Market by Region
4.2: North American Migraine Drugs Market
4.2.1: North American Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.2.2: North American Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Migraine Drugs Market
4.3.1: European Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.3.2: European Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Migraine Drugs Market
4.4.1: APAC Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.4.2: APAC Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Migraine Drugs Market
4.5.1: ROW Migraine Drugs Market by Product Type: Acute Migraine Treatment and Preventive Migraine Treatment
4.5.2: ROW Migraine Drugs Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
5. COMPETITOR ANALYSIS
5.1: Product Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Migraine Drugs Market by Product Type
6.1.2: Growth Opportunities for the Global Migraine Drugs Market by Route of Administration
6.1.3: Growth Opportunities for the Global Migraine Drugs Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Migraine Drugs Market by Region
6.2: Emerging Trends in the Global Migraine Drugs Market
6.3: Strategic Analysis
6.3.1: New Product Type Development
6.3.2: Capacity Expansion of the Global Migraine Drugs Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Migraine Drugs Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Allergan
7.2: Abbott Laboratories
7.3: AstraZeneca
7.4: Endo International
7.5: Eisai
7.6: Impax Laboratories
7.7: GlaxoSmithKline
7.8: Johnson & Johnson
7.9: Pfizer
7.9: Merck & Co.
7.10: Sanofi SA
